Clinical Trial Update: Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) [Phase 3]

View source ↗

Summary

Phase 3 trial of inhaled treprostinil for pulmonary hypertension due to chronic obstructive pulmonary disease was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• Treprostinil (inhaled) (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease | Phase 3 | Status: TERMINATED | Results posted: 2023-12-18